|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-10-3
|
|
pubmed:abstractText |
The effect of exogenous hormones on the incidence of breast cancer has been extensively studied. Most studies regarding hormonal contraception have focused on combined oral contraceptives, and there is paucity of literature regarding nonoral and progestin-only contraceptives. The present study analyzed the relationship between breast cancer and use of the levonorgestrel-releasing intrauterine system.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0029-7844
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
106
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
813-7
|
|
pubmed:dateRevised |
2009-10-26
|
|
pubmed:meshHeading |
pubmed-meshheading:16199640-Adult,
pubmed-meshheading:16199640-Age Distribution,
pubmed-meshheading:16199640-Aged,
pubmed-meshheading:16199640-Breast Neoplasms,
pubmed-meshheading:16199640-Case-Control Studies,
pubmed-meshheading:16199640-Contraceptive Agents, Female,
pubmed-meshheading:16199640-Female,
pubmed-meshheading:16199640-Finland,
pubmed-meshheading:16199640-Humans,
pubmed-meshheading:16199640-Incidence,
pubmed-meshheading:16199640-Intrauterine Devices, Medicated,
pubmed-meshheading:16199640-Levonorgestrel,
pubmed-meshheading:16199640-Middle Aged,
pubmed-meshheading:16199640-Product Surveillance, Postmarketing
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Use of the levonorgestrel-releasing intrauterine system and breast cancer.
|
|
pubmed:affiliation |
Turku University Central Hospital, Turku, Finland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
